253 related articles for article (PubMed ID: 21233187)
1. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
J Nucl Med; 2011 Feb; 52(2):279-86. PubMed ID: 21233187
[TBL] [Abstract][Full Text] [Related]
2. In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
Contrast Media Mol Imaging; 2015; 10(1):59-66. PubMed ID: 24823643
[TBL] [Abstract][Full Text] [Related]
3. Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes.
van Duijnhoven SM; Robillard MS; Hermann S; Kuhlmann MT; Schäfers M; Nicolay K; Grüll H
Mol Pharm; 2014 May; 11(5):1415-23. PubMed ID: 24641497
[TBL] [Abstract][Full Text] [Related]
4. Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.
Shi NQ; Gao W; Xiang B; Qi XR
Int J Nanomedicine; 2012; 7():1613-21. PubMed ID: 22619516
[TBL] [Abstract][Full Text] [Related]
5. Development of Radiolabeled Membrane Type-1 Matrix Metalloproteinase Activatable Cell Penetrating Peptide Imaging Probes.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
Molecules; 2015 Jul; 20(7):12076-92. PubMed ID: 26147581
[TBL] [Abstract][Full Text] [Related]
6. Protease-Activable Cell-Penetrating Peptide-Protoporphyrin Conjugate for Targeted Photodynamic Therapy in Vivo.
Li SY; Cheng H; Qiu WX; Liu LH; Chen S; Hu Y; Xie BR; Li B; Zhang XZ
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28319-29. PubMed ID: 26634784
[TBL] [Abstract][Full Text] [Related]
7. Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides.
Aguilera TA; Olson ES; Timmers MM; Jiang T; Tsien RY
Integr Biol (Camb); 2009 Jun; 1(5-6):371-81. PubMed ID: 20023744
[TBL] [Abstract][Full Text] [Related]
8. Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide.
Kuhnast B; Bodenstein C; Haubner R; Wester HJ; Senekowitsch-Schmidtke R; Schwaiger M; Weber WA
Nucl Med Biol; 2004 Apr; 31(3):337-44. PubMed ID: 15028246
[TBL] [Abstract][Full Text] [Related]
9. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer.
Olson ES; Aguilera TA; Jiang T; Ellies LG; Nguyen QT; Wong EH; Gross LA; Tsien RY
Integr Biol (Camb); 2009 Jun; 1(5-6):382-93. PubMed ID: 20023745
[TBL] [Abstract][Full Text] [Related]
10. Dual targeting of integrin αvβ3 and matrix metalloproteinase-2 for optical imaging of tumors and chemotherapeutic delivery.
Crisp JL; Savariar EN; Glasgow HL; Ellies LG; Whitney MA; Tsien RY
Mol Cancer Ther; 2014 Jun; 13(6):1514-25. PubMed ID: 24737028
[TBL] [Abstract][Full Text] [Related]
11. Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma.
Felsen CN; Savariar EN; Whitney M; Tsien RY
Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(8):L764-74. PubMed ID: 24508733
[TBL] [Abstract][Full Text] [Related]
12. Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke.
Chen S; Cui J; Jiang T; Olson ES; Cai QY; Yang M; Wu W; Guthrie JM; Robertson JD; Lipton SA; Ma L; Tsien RY; Gu Z
J Cereb Blood Flow Metab; 2017 Jan; 37(1):188-200. PubMed ID: 26681768
[TBL] [Abstract][Full Text] [Related]
13. The targeted transduction of MMP-overexpressing tumor cells by ACPP-HPMA copolymer-coated adenovirus conjugates.
Li S; Chen J; Xu H; Long J; Xie X; Zhang Y
PLoS One; 2014; 9(7):e100670. PubMed ID: 25000246
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
Giblin MF; Sieckman GL; Shelton TD; Hoffman TJ; Forte LR; Volkert WA
Nucl Med Biol; 2006 May; 33(4):481-8. PubMed ID: 16720239
[TBL] [Abstract][Full Text] [Related]
15. [The design and enzymatic hydrolysis of activatable cell-penetrating peptide].
Wang PC; Qi XR
Yao Xue Xue Bao; 2010 Aug; 45(8):1048-51. PubMed ID: 21351594
[TBL] [Abstract][Full Text] [Related]
16. Tumor imaging by means of proteolytic activation of cell-penetrating peptides.
Jiang T; Olson ES; Nguyen QT; Roy M; Jennings PA; Tsien RY
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17867-72. PubMed ID: 15601762
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human lung cancer cells by anti-p21Ras scFv mediated by the activatable cell-penetrating peptide.
Du Y; Lin X; Feng Q; Pan X; Song S; Yang J
Anticancer Drugs; 2022 Jan; 33(1):e562-e572. PubMed ID: 34338241
[TBL] [Abstract][Full Text] [Related]
18. Hydrolysis Mechanism of the Linkers by Matrix Metalloproteinase-9 Using QM/MM Calculations.
Chen B; Kang Z; Zheng E; Liu Y; Gauld JW; Wang Q
J Chem Inf Model; 2021 Oct; 61(10):5203-5211. PubMed ID: 34649435
[TBL] [Abstract][Full Text] [Related]
19. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.
Olson ES; Whitney MA; Friedman B; Aguilera TA; Crisp JL; Baik FM; Jiang T; Baird SM; Tsimikas S; Tsien RY; Nguyen QT
Integr Biol (Camb); 2012 Jun; 4(6):595-605. PubMed ID: 22534729
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester.
Zheng QH; Fei X; DeGrado TR; Wang JQ; Stone KL; Martinez TD; Gay DJ; Baity WL; Mock BH; Glick-Wilson BE; Sullivan ML; Miller KD; Sledge GW; Hutchins GD
Nucl Med Biol; 2003 Oct; 30(7):753-60. PubMed ID: 14499334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]